标普和纳斯达克内在价值 联系我们

ANI Pharmaceuticals, Inc. ANIP NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
70/100
3/7 Pass
SharesGrow Intrinsic Value
$482.01
+515.7%
Analyst Price Target
$107.00
+36.7%

ANI Pharmaceuticals, Inc. (ANIP) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业. 公司总部位于 Baudette, MN, 美国. 现任CEO为 Nikhil Lalwani.

ANIP 拥有 IPO日期为 2000-05-05, 897 名全职员工, 在 NASDAQ Global Market, 市值为 $1.75B.

关于 ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

📍 210 Main Street West, Baudette, MN 56623 📞 218 634 3500
公司详情
所属板块医疗保健
细分行业制药 - 专科与仿制药
国家美国
交易所NASDAQ Global Market
货币USD
IPO日期2000-05-05
首席执行官Nikhil Lalwani
员工数897
交易信息
当前价格$78.29
市值$1.75B
52周区间56.71-99.5
Beta0.44
ETF
ADR
CUSIP00182C103
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言